BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38213063)

  • 1. Characterization of Demographical Histologic Diversity in Small Renal Masses With the Clear Cell Likelihood Score.
    Vazquez LC; Xi Y; Rasmussen RG; Venzor JER; Kapur P; Zhong H; Dai JC; Morgan TN; Cadeddu JA; Pedrosa I
    J Comput Assist Tomogr; 2024 May-Jun 01; 48(3):370-377. PubMed ID: 38213063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter Evaluation of Multiparametric MRI Clear Cell Likelihood Scores in Solid Indeterminate Small Renal Masses.
    Schieda N; Davenport MS; Silverman SG; Bagga B; Barkmeier D; Blank Z; Curci NE; Doshi AM; Downey RT; Edney E; Granader E; Gujrathi I; Hibbert RM; Hindman N; Walsh C; Ramsay T; Shinagare AB; Pedrosa I
    Radiology; 2022 Jun; 303(3):590-599. PubMed ID: 35289659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Clear Cell Likelihood Score on MRI and Growth Kinetics of Small Solid Renal Masses on Active Surveillance.
    Rasmussen RG; Xi Y; Sibley RC; Lee CJ; Cadeddu JA; Pedrosa I
    AJR Am J Roentgenol; 2022 Jan; 218(1):101-110. PubMed ID: 34286596
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic Performance and Interreader Agreement of the MRI Clear Cell Likelihood Score for Characterization of cT1a and cT1b Solid Renal Masses: An External Validation Study.
    Dunn M; Linehan V; Clarke SE; Keough V; Nelson R; Costa AF
    AJR Am J Roentgenol; 2022 Nov; 219(5):793-803. PubMed ID: 35642765
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospective performance of clear cell likelihood scores (ccLS) in renal masses evaluated with multiparametric magnetic resonance imaging.
    Steinberg RL; Rasmussen RG; Johnson BA; Ghandour R; De Leon AD; Xi Y; Yokoo T; Kim S; Kapur P; Cadeddu JA; Pedrosa I
    Eur Radiol; 2021 Jan; 31(1):314-324. PubMed ID: 32770377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of prospectively assigned clear cell Likelihood scores (ccLS) in small renal masses at multiparametric magnetic resonance imaging.
    Johnson BA; Kim S; Steinberg RL; de Leon AD; Pedrosa I; Cadeddu JA
    Urol Oncol; 2019 Dec; 37(12):941-946. PubMed ID: 31540830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation between renal epithelioid angiomyolipoma and clear cell renal cell carcinoma using clear cell likelihood score.
    Hao YW; Zhang Y; Guo HP; Xu W; Bai X; Zhao J; Ding XH; Gao S; Cui MQ; Liu BC; Ye HY; Wang HY
    Abdom Radiol (NY); 2023 Dec; 48(12):3714-3727. PubMed ID: 37747536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of diagnostic performance of Clear Cell Likelihood Score v1.0 and v2.0 for clear renal cell carcinoma].
    Hao Y; Gao S; Zhang X; Cui M; Ding X; Wang H; Yang D; Ye H; Wang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 May; 43(5):800-806. PubMed ID: 37313822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of clear cell likelihood scores in characterizing solid renal masses at multiparametric MRI: an external validation study.
    Ibrahim A; Pelsser V; Anidjar M; Kaitoukov Y; Camlioglu E; Moosavi B
    Abdom Radiol (NY); 2023 Mar; 48(3):1033-1043. PubMed ID: 36639532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of clear cell likelihood score in differentiation between renal oncocytoma and clear cell renal cell carcinoma].
    Cui MQ; He B; Xu W; Hao YW; Ding XH; Wang S; Bai X; Liu BC; Ye HY; Wang HY
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(47):3779-3785. PubMed ID: 36517429
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal Mass Imaging with MRI Clear Cell Likelihood Score: A User's Guide.
    Shetty AS; Fraum TJ; Ballard DH; Hoegger MJ; Itani M; Rajput MZ; Lanier MH; Cusworth BM; Mehrsheikh AL; Cabrera-Lebron JA; Chu J; Cunningham CR; Hirschi RS; Mokkarala M; Unteriner JG; Kim EH; Siegel CL; Ludwig DR
    Radiographics; 2023 Jul; 43(7):e220209. PubMed ID: 37319026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and meta-analysis of multiparametric MRI clear cell likelihood scores for classification of small renal masses.
    Tian J; Teng F; Xu H; Zhang D; Chi Y; Zhang H
    Front Oncol; 2022; 12():1004502. PubMed ID: 36387185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort.
    Finelli A; Cheung DC; Al-Matar A; Evans AJ; Morash CG; Pautler SE; Siemens DR; Tanguay S; Rendon RA; Gleave ME; Drachenberg DE; Chin JL; Fleshner NE; Haider MA; Kachura JR; Sykes J; Jewett MAS
    Eur Urol; 2020 Sep; 78(3):460-467. PubMed ID: 32680677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Risk Factors Associated With Small Renal Mass Malignant Histology in a Multi-Ethnic Population Undergoing Partial Nephrectomy.
    Zhu D; Loloi J; Labagnara K; Schwartz D; Agalliu I; Fram EB; Sankin A; Aboumohamed A; Kovac E
    Clin Genitourin Cancer; 2022 Dec; 20(6):e465-e472. PubMed ID: 35768315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metastatic potential of renal tumors: Influence of histologic subtypes on definition of small renal masses, risk stratification, and future active surveillance protocols.
    Daugherty M; Sedaghatpour D; Shapiro O; Vourganti S; Kutikov A; Bratslavsky G
    Urol Oncol; 2017 Apr; 35(4):153.e15-153.e20. PubMed ID: 28202224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Multiparametric Renal CT Algorithm for Diagnosis of Clear Cell Renal Cell Carcinoma Among Small (≤ 4 cm) Solid Renal Masses.
    Al Nasibi K; Pickovsky JS; Eldehimi F; Flood TA; Lavallee LT; Tsampalieros AK; Schieda N
    AJR Am J Roentgenol; 2022 Nov; 219(5):814-823. PubMed ID: 35766532
    [No Abstract]   [Full Text] [Related]  

  • 17. Racial/ethnic disparities in renal cell carcinoma: Increased risk of early-onset and variation in histologic subtypes.
    Batai K; Harb-De la Rosa A; Zeng J; Chipollini JJ; Gachupin FC; Lee BR
    Cancer Med; 2019 Nov; 8(15):6780-6788. PubMed ID: 31509346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiologic heterogeneity of clear-cell and papillary renal cell carcinoma in the Netherlands Cohort Study.
    van de Pol JAA; George L; van den Brandt PA; Baldewijns MMLL; Schouten LJ
    Int J Cancer; 2021 Jan; 148(1):67-76. PubMed ID: 32638386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma.
    Pierorazio PM; Hyams ES; Tsai S; Feng Z; Trock BJ; Mullins JK; Johnson PT; Fishman EK; Allaf ME
    Urology; 2013 Jun; 81(6):1265-71. PubMed ID: 23601445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral fat accumulation is associated with different pathological subtypes of renal cell carcinoma (RCC): a multicentre study in China.
    Wang HK; Song XS; Cheng Y; Qu YY; Zhang SL; Dai B; Zhang HL; Shen YJ; Zhu YP; Shi GH; Qin XJ; Ma CG; Lin GW; Xiao WJ; Zhu Y; Ye DW
    BJU Int; 2014 Oct; 114(4):496-502. PubMed ID: 25383400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.